Skip to main content
TipRanks
Go Ultimate75% OFF

Avenue Therapeutics (49Y) Q2 2023 Earnings Report

1 Followers

DE:49Y Q2 2023 EPS Results

Actual EPS
-EUR 34.29
Consensus EPS
-EUR 19.12
Beat/Miss
Missed by -EUR 15.17
One Year Ago EPS
-EUR 27.26

DE:49Y Q2 2023 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
EUR 0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
08/10/2023
Time
After Close
Conference Call
Thursday, August 10, 2023

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:49Y Earnings History

DE:49Y earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 17, 20252025 (Q3)―-0.19-1.6988.85% (+1.50)
Aug 18, 20252025 (Q2)―0.09-5.65101.63% (+5.75)
May 19, 20252025 (Q1)―-0.55-13.5495.95% (+12.99)
Mar 25, 20252024 (Q4)-0.50-0.6456.05-101.15% (-56.70)
Nov 14, 20242024 (Q3)-0.83-1.693.96-142.67% (-5.64)
Aug 09, 20242024 (Q2)-0.92-5.65-34.2983.51% (+28.64)
May 15, 20242024 (Q1)-7.91-13.54-90.3485.01% (+76.80)
Mar 18, 20242023 (Q4)-6.5956.058.57553.85% (+47.48)
Nov 13, 20232023 (Q3)-17.153.96-29.67113.33% (+33.63)
Aug 10, 20232023 (Q2)-19.12-34.29-27.26-25.79% (-7.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed